| Literature DB >> 35002681 |
Xin Yu1, Hong-Ying Jiang2, Chen-Xi Zhang2, Zhao-Hui Jin3, Lei Gao3, Rui-Dan Wang3, Jin-Ping Fang3, Yuan Su3, Jia-Ning Xi2, Bo-Yan Fang3.
Abstract
Background: In normal subjects, the diaphragm plays a key functional role in postural stability, articulation, respiration, defecation, and urination.Entities:
Keywords: Parkinson’s disease; diaphragm; motor subtypes; postural stability; visceral function
Year: 2021 PMID: 35002681 PMCID: PMC8733584 DOI: 10.3389/fnagi.2021.785020
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
FIGURE 1The measurement of diaphragmatic thickness and excursion. (A) A 10–15 MHz probe was placed at the zone of apposition. (B) The non-echogenic layer between the yellow markers indicates the thickness of the diaphragm at the end of expiration and inspiration. (C) A 2–5 MHz curved-array probe was placed under the costal margin. (D) The bright line indicates diaphragmatic excursion during deep breathing. DTEE, diaphragm thickness at end-expiratory; DTEI, diaphragm thickness at end-inspiration; DEDB, diaphragmatic excursion during deep breathing.
Clinical features and diaphragm function in patients with Parkinson’s disease.
| Characteristic | Overall Cohort ( | Male | Female | Abnormal value | |
|
| |||||
| Age (year) | 61.5 (9) | 64 (13) | 61 (8) | 0.2 | / |
| Disease duration (months) | 78 (60) | 6 (5.42) | 7 (4.3) | 0.5 | / |
| Gender (male), n (%) | 35 (44.3%) | 35 (44.3%) | 44 (55.7%) | / | |
| Hoehn & Yahr stage, n (%) | 0.6 | / | |||
| Stage 1–1.5 | 6 (7.6%) | 4 | 2 | / | |
| Stage 2 | 39 (49.4%) | 18 | 21 | / | |
| Stage 2.5 | 16 (20.3%) | 7 | 9 | / | |
| Stage 3 | 18 (22.8%) | 6 | 12 | / | |
| PDQ-39 (score) | 23.07 (13.46) | 21.15 (11.3) | 25.96 (12.83) |
| / |
| MDS-UPDRS III-ON (score) | 30.57 ± 12.48 | 31.17 ± 13 | 30.67 ± 11 | 0.9 | / |
| MDS-UPDRS III-OFF (score) | 38.87 ± 14.17 | 37.68 ± 12.2 | 38.12 ± 14.6 | 0.9 | / |
|
| |||||
| Eyes open (cm/s) | 2.78 (0.98) | 2.5 (1.1) | 2.8 (0.9) | 0.2 | / |
| Eyes closed (cm/s) | 2.83 (0.86) | 2.7 (1.0) | 2.9 (0.7) | 0.14 | / |
| Tandem standing (cm/s) | 4.16 (1.90) | 5.3 (2.3) | 3.8 (1.1) | < 0.001* | / |
|
| |||||
| VHI-10 (score) | 8 (7) | 9 (8) | 7 (7) | 0.14 | >7.5 |
|
| |||||
| VC (% of predicted) | 100.48 ± 18.76 | 93.67 ± 14.56 | 105.89 ± 27.8 |
| <80 |
| FVC (% of predicted) | 95.47 ± 15.40 | 92.23 ± 14.22 | 98.03 ± 22.5 | 0.1 | <80 |
| FEV1 (% of predicted) | 91.10 ± 14.82 | 90.36 ± 13.67 | 91.61 ± 15.81 | 0.7 | <80 |
| FEV1/FVC (%) | 78.12 ± 4.94 | 75.8 (6.5) | 79.7 (5.2) | 0.2 | <70 |
|
| |||||
| BFI (score) | 46.67 (53.33) | 56.7 (53.3) | 40 (48.75) | 0.2 | >29 |
| PAC-QoL (score) | 48 (20.05) | 54 (37) | 47 (31) | 0.5 | / |
|
| |||||
| ICIQ-OAB (score) | 4 (3) | 4.8 (4) | 4 (2) | 0.4 | Mild: 0–7; Moderate: 8–19; Severe: >20 |
| IPSS (score) | 8 (13) | 8 (13) | / | / | |
|
| |||||
| DTEE (cm) |
|
|
|
| Men: <0.17; Women: <0.13 |
| DTEI (cm) |
|
|
|
| |
| DTF (%) | 62 (43) | 68 (56) | 57.5 (42) | 0.26 | <20 |
| DEQB (R) (cm) |
|
|
|
| Men: <1; Women: <0.9 |
| DESniff (R) (cm) | 4.35 ± 1.47 | 4.63 ± 1.51 | 4.12 ± 1.42 | 0.13 | Men: <1.8; Women: <1.6 |
| DEDB (R) (cm) | 4.89 ± 1.32 | 5.20 ± 1.43 | 4.64 ± 1.19 | 0.06 | Men: <4.7; Women: <3.7 |
| DVQB (R) (cm/s) | 1.07 (0.32) | 1.09 (0.32) | 1.02 (0.30) | 0.13 | / |
| DVSniff (R) (cm/s) | 3.77 (1.8) | 3.98 (2.34) | 3.66 (1.39) | 0.40 | / |
| DEQB (L) (cm) | 1.24 (0.53) | 1.33 (0.74) | 1.21 (0.48) | 0.24 | / |
| DESniff (L) (cm) | 3.96 ± 1.3 | 4.02 ± 1.39 | 3.92 ± 1.24 | 0.74 | / |
| DEDB (L) (cm) | 4.19 ± 1.23 | 4.16 ± 1.34 | 4.22 ± 1.15 | 0.82 | / |
| DVQB (L) (cm/s) | 1.05 (0.41) | 1.05 (0.49) | 1.05 (0.37) | 0.64 | / |
| DVSniff (L) (cm/s) | 3.78 (1.62) | 3.57 (1.97) | 3.78 (1.26) | 0.45 | / |
Data are expressed as means ± SD if normally distributed; otherwise, data are shown as medians with interquartile ranges (IQRs). *p < 0.05 (two-tailed) defined as being statistically significant and was shown in bold. n, number; PDQ-39, 39-item Parkinson’s Disease Questionnaire; MDS-UPDRS, Movement Disorder Society-Unified Parkinson’s Disease Rating Scale; COP, center of pressure; VHI-10, Voice Handicap Index-10; VC, vital capacity; FVC, forced vital capacity; FEV
FIGURE 2Comparison of diaphragm function between different Hoehn and Yahr (H&Y) stages. *p < 0.05; **p < 0.01. DTEI, diaphragm thickness at end-inspiration; DEQB, diaphragmatic excursion during quiet breathing; DVQB, diaphragm velocity during quiet breathing.
Main diaphragmatic parameters associated with postural stability and visceral function selected by the least absolute shrinkage and selection operator (LASSO) regression and the principal component analysis and fitted in the multivariate linear regression.
| Adjusted | Standard β coefficient | ||
|
| |||
|
| 0.08 | ||
| DVsniff (R) | 0.29 |
| |
|
| 0.06 | ||
| DVsniff (R) | 0.28 |
| |
|
| 0.15 | ||
| PC 1 | 0.4 |
| |
|
| 0.08 | ||
| DEsniff (R) | –0.3 |
| |
|
| |||
|
| 0.09 | ||
| DVQB (L) | –0.27 |
| |
| Gender | 0.16 | 0.14 | |
|
| 0.09 | ||
| DVQB (L) | –0.34 |
| |
| DVQB (R) | 0.25 |
| |
|
| |||
|
| 0.26 | ||
| Age | 0.26 |
| |
| DVQB (L) | –0.26 |
| |
| DESniff (L) | –0.46 |
| |
|
| 0.06 | ||
| DEDB (L) | 0.19 | 0.09 | |
| Age | 0.27 |
| |
|
| |||
|
| 0.26 | ||
| DVsniff (L) | 0.41 |
| |
| Age | 0.34 |
| |
|
| 0.32 | ||
| DTEE | –0.34 |
| |
| Age | 0.45 |
|
*p < 0.05 presented in bold. COP, center of pressure; L, left; R, right; DV
FIGURE 3Pearson’s correlation analysis between the diaphragm and voice (A), respiratory (B), intestinal (C), postural stability (D), and urological function (E). p < 0.05 was considered to be statistically significant. VHI-10, voice handicap index-10; PC, principal component; FVC, forced vital capacity; FEV1, forced expiratory volume during the first second; BFI, Bowel Function Index; PAC-QoL, Patient Assessment of Constipation Quality of Life; ICIQ-OAB, International Consultation on Incontinence Questionnaire for Overactive Bladder; IPSS, International Prostate Symptom Score; COP, center of pressure.